In conclusion, CPG administration could remarkably inhibit the transplanted tumor growth in mice with an inhibitory ratio of 45.37% and significantly improve the expression of IL-2, IFN-γ, and TNF-α. The gene discussed is IFNG; the disease is neoplasm.